All AbMole products are for research use only, cannot be used for human consumption.
BAY-60-7550 is a potent Type 2 cyclic nucleotide phosphodiesterases (PDE2) inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human). BAY-60-7550 is an analog of EHNA, which is more than 100-fold more potent and is highly selective for PDE2A.
 |
Source | Neurobiol Aging (2015). Figure 1. BAY-60-7550 |
| Method | i.v. | |
| Cell Lines | mice | |
| Concentrations | 3 mg/kg | |
| Incubation Time | 24 h | |
| Results | Bay 60-7550-treated mice (3 mg/kg) took significantly less time to reach the platform position, and made more crossings over the platform, than stressed mice |
| Cell Experiment | |
|---|---|
| Cell lines | human distal pulmonary artery smooth muscle cells |
| Preparation method | Cell proliferation. Growth of human distal pulmonary artery smooth muscle cells isolated from patients with idiopathic pulmonary arterial hypertension (IPAH) or control cells from adults undergoing transplant or lung resection for suspected malignancy, were monitored as we have described previously 29 following treatment with BAY 60-7550 (1μmol/L), ANP (1μmol/L), DETA-NONOate (10μmol/L), or treprostinil (1μmol/L), alone or in combination. |
| Concentrations | 1μmol/L |
| Incubation time | unknow |
| Animal Experiment | |
|---|---|
| Animal models | Oxidative Stress on Behavior in mice |
| Formulation | dissolved in 50% dimethyl sulfoxide (Fisher Scientific Co., Pittsburgh, PA) |
| Dosages | 3 mg/kg; given 30 min before each BSO treatment |
| Administration | i.p. |
| Molecular Weight | 476.57 |
| Formula | C27H32N4O4 |
| CAS Number | 439083-90-6 |
| Solubility (25°C) | DMSO 5 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Ren et al. Hypertension. Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.
| Related PDE Products |
|---|
| MR-L2
MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM. |
| MMPX
MMPX is a potent PDE1 inhibitor. |
| T-0156
T-0156 is a potent and selective phosphodiesterase type 5 (PDE5) inhibitor. |
| TPN171
TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 (PDE5) with an IC50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH). |
| Mesopram
Mesopram (Daxalipram) is an orally active phosphodiesterase (PDE) 4 inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
